首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Renal function evaluated with clearance studies in humans.
【24h】

Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Renal function evaluated with clearance studies in humans.

机译:依那普利和尼群地平对心钠素对心钠素反应的相反作用。肾脏功能通过人类清除研究评估。

获取原文
       

摘要

In clearance studies, we analyzed the effect of Ca2+ entry blockade with nitrendipine treatment (20 mg b.i.d. for 4 days) and of converting enzyme inhibition with enalapril treatment (20 mg b.i.d. for 4 days) on renal response to atrial natriuretic factor (ANF) (25 micrograms bolus followed by an infusion of 0.03 microgram/kg/min for 90 minutes) in six healthy volunteers who were taking 300 mmol sodium daily. In a control study ANF was administered without Ca2+ entry blockade or converting enzyme inhibition. Natriuresis rose from 239 +/- 38 to 605 +/- 137 mumol/min in the control study (p less than 0.05), from 330 +/- 53 to 943 +/- 152 mumol/min with Ca2+ entry blockade (p less than 0.05), and from 236 +/- 22 to 344 +/- 39 mumol/min with converting enzyme inhibition (NS). ANF induced a rise in maximal free water clearance, inulin clearance, and in the excretion of multiple electrolytes except potassium. Fractional lithium reabsorption fell. In general, these effects were stronger during Ca2+ entry blockade and blunted during converting enzyme inhibition. p-Aminohippurate clearance tended to decrease during the control study (NS), remained constant during Ca2+ entry blockade, and decreased significantly when ANF was infused during converting enzyme inhibition (p less than 0.05 vs. control and vs. Ca2+ entry blockade study). Blood pressure was lowered by Ca2+ entry blockade and, to a somewhat greater extent, by converting enzyme inhibition, but ANF administration induced no additional fall except for a short-term drop during Ca2+ entry blockade.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:在清除研究中,我们分析了尼群地平治疗(20 mg bid,为期4天)和依那普利治疗(20 mg bid,为期4天)对Ca2 +进入阻滞的转化对肾对心钠素(ANF)的反应的影响(在六名每天服用300 mmol钠的健康志愿者中,先进行25毫克推注,然后再输注0.03毫克/千克/分钟,持续90分钟。在一项对照研究中,给予ANF时无Ca2 +进入阻滞或转化酶抑制作用。对照研究中的利尿钠排泄从239 +/- 38升至605 +/- 137摩尔/分钟(p小于0.05),由Ca2 +进入阻滞从330 +/- 53升至943 +/- 152摩尔/分钟(p小于大于0.05),并且从236 +/- 22到344 +/- 39μmol/ min的转化酶抑制(NS)。 ANF导致最大游离水清除率,菊粉清除率以及除钾以外的多种电解质的排泄增加。锂的部分重吸收下降。通常,这些作用在Ca2 +进入封锁期间更强,而在转化酶抑制期间则减弱。在对照研究(NS)中,p-氨基马尿酸盐清除率趋于下降,在Ca2 +进入封锁期间保持恒定,而在转化酶抑制过程中注入ANF时,p-氨基马尿酸盐清除率则显着下降(与对照和Ca2 +进入封锁研究相比,p小于0.05)。通过Ca2 +进入阻滞降低了血压,并且通过转换酶抑制作用在一定程度上降低了血压,但是ANF的使用除了在Ca2 +进入阻滞期间的短期下降外,没有引起其他的下降。(摘要截断为250个字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号